Did you buy Similasan eye drops in the last several years expecting relief from dry or irritated eyes? You may be eligible for compensation. If you’re familiar with our updates on class actions like the Huggies baby wipes class action lawsuit or Jeep class action lawsuit, you’ll know Sparrow is the fastest way to turn your receipts into real money. Now, Similasan—a popular homeopathic brand—is settling a $3.575 million lawsuit over allegedly misleading marketing claims.
If you’ve purchased homeopathic eye drops from Similasan, CVS, or Walgreens in the past several years, you might be eligible for compensation. The recent $3.575 million Similasan eye drop class action settlement was reached to resolve allegations of deceptive marketing practices and mislabeling, particularly concerning the use of the term “homeopathic” and the labeling of the products as “sterile.”
Just as Sparrow has helped consumers navigate complex settlements like the Broiler Chicken antitrust lawsuit and the Retina Group of Washington data breach, this guide will break down everything you need to know about the Similasan case—including who qualifies, what you could receive, and how Sparrow can help you file fast and effectively.
Background of the Case
This class action lawsuit, Plowden, et al. v. Similasan Corp., claims that Similasan and its private label partners CVS and Walgreens misled customers by advertising their eye drops as “homeopathic,” “plant-based,” or “sterile”—without disclosing the risk of silver sulfate, a preservative.
The products in question were sold between Sept. 11, 2017, and Feb. 20, 2025, and include popular items like:
- Similasan Dry Eye Relief
- Similasan Pink Eye Relief
- CVS Pink Eye Drops
- Walgreens Stye Eye Drops
Plaintiffs argued these claims misled consumers into paying more for what they believed were safer, natural products. The lawsuit alleged that many of the ingredients—such as sodium carbonate and silver sulfate—are synthetic or not truly plant-based. While Similasan denies wrongdoing, it chose to settle to avoid continued litigation.
This case adds to growing scrutiny of so-called “natural” or “homeopathic” remedies, as seen in prior lawsuits involving dietary supplements and skincare products.
Who’s Eligible for the Similasan Eye Drop Class Action Settlement?
You qualify if you purchased any of the covered products for personal use between Sept. 11, 2017, and Feb. 20, 2025. Covered products include:
- Similasan brand: Dry Eye Relief, Complete Eye Relief, Allergy Eye Relief, Kids Allergy Eye Relief, Red Eye Relief, Pink Eye Relief, Kids Pink Eye Relief, Aging Eye Relief, Computer Eye Relief, Stye Eye Relief, Pink Eye Nighttime Gel, Dry Eye Nighttime Gel
- CVS brand: Pink Eye Drops
- Walgreens brand: Stye Eye Drops, Pink Eye Drops, Allergy Eye Drops
Purchases must have been made in the United States and not for resale. The settlement is limited to one claim per household.
How Much You Can Get
Settlement amounts vary based on whether you have proof of purchase:
- Without Proof of Purchase:
- $2.50 per product, up to $10 per household (max 4 products).
- With Valid Proof of Purchase (receipts, packaging, etc.):
- $2.50 per product with no cap.
All claims are subject to a pro rata adjustment, meaning your final payment may increase or decrease based on the total number of valid claims.
How to File a Claim with Sparrow
Filing is simple, especially with Sparrow:
- Visit the official settlement site: HomeopathicEyeDropSettlement.com for FAQs and eligible criteria.
- Gather your proof of purchase (if you have any). Acceptable formats include store receipts, order confirmations, or product packaging.
- Head over to Sparrow’s settlement claim portal and select the Similasan Eye Drop Settlement.
- Complete the form and upload your documents (if applicable).
- Submit and relax—Sparrow handles the legwork, ensuring your claim is optimized for maximum payout.
Important Deadlines
- Claim Filing Deadline: October 15, 2025
- Exclusion/Objection Deadline: May 27, 2025
- Final Approval Hearing: July 17, 2025
Case Details
- Case Name: Plowden, et al. v. Similasan Corp., Case No. 1:23-cv-02511-DDD-STV
- Court: U.S. District Court for the District of Colorado
- Settlement Website: HomeopathicEyeDropSettlement.com
- Claims Administrator:
- Homeopathic Eye Drop Settlement
- 1650 Arch Street, Suite 2210, Philadelphia, PA 19103
- Phone: 855-596-4080
Why This Matters—and What to Do Next
Consumer trust is often tied to product transparency. This lawsuit highlights the fine print many brands fail to disclose—especially in the health and wellness market. If you’ve trusted Similasan, Walgreens, or CVS homeopathic eye drops to be plant-based or sterile, you deserve clarity—and potentially compensation.
If you’ve previously filed claims through Sparrow for similar product-related cases, like the Botanic Tonics kratom settlement, you already know how simple the process can be. Sparrow removes the complexity and keeps you updated every step of the way.
Conclusion
The Similasan eye drop class action settlement is a chance for everyday consumers to reclaim what they’re owed. If you bought covered products between 2017 and 2025, act before October 15, 2025 to file your claim. You could receive up to $10 without proof or more with receipts. Don’t let the deadline pass.
Let Sparrow help you file today—your vision deserves more than vague labels. And while you’re at it, browse other open class action settlements to see what else you may be entitled to. Because with Sparrow, every dollar counts.
